118. Graff LA, Walker JR, Lix LM. The relationship of inflammatory bowel disease type and activity with psychological functioning and quality of life. Clin Gastroentrol Hepatol 2006; 4: 1491-1501.
119. Walker JR, Ediger JP, Graff LA et al. The Manitoba IBD cohort study: a population – based study of the prevalence of lifetime and 12-month anxiety and mood disorders. AM J Gastroenterol 2008; 103: 1989-97.
120. Graff LA, Vincent N, Walker JR et al. A population-based study of fatigue and sleep difficulties in inflammatory bowel disease. Inflamm Bowel Dis 2011; 17: 1882-9.
121. Vidal A, Gomez-Gil E, Sans M. Health-related quality of life in inflammatory bowel disease patients: the role of psychopathology and personality. Inflamm Bowel Dis 2008; 14: 977-83.
122. Solomon D, Holley D BUch M et al. An international survey of ulcerative colitis: perspectives from patients and healthcare professionals. ECCO abstracts: Barcelona, February 2012
123. Griffiths AM, Nicholas D, Smith C, et al. Development of a quality-of-life index for pediatric inflammatory bowel disease: dealing with differences related to age and IBD type. J Pediatr Gastroenterol Nutr 1999; 28:S46–S52
124. Loonen HJ, Grootenhuis MA, Last BF. Quality of life in paediatric inflammatory bowel disease measured by a generic and a disease-specific instrument. Acta Paediatr 2002; 91: 348-54.
126. Scarpa M, Ruffolo C, D’Inca R et al. Health-related quality of life after ileocolonic resection for Crohn’s disease: long-term results. Inflamm Bowel Dis 2007; 13: 462-9.
127. Camilleri-Brennan J, Steele RJ. Objective assessment of quality of life after panproctocolectomy and ileostomy for ulcerative colitis. Ann R Coll Surg Engl 2001; 83; 321-4.
125. De Boer M, Grootenhuis M, Derkx B et al. Health-related quality of life and psychosocial functioning in adolescent boys with inflammatory bowel disease. Inflamm Bowel Dis 2005; 11: 400-6.
128. Bernklev T, Jahnsen J, Schulz T et al. Course of disease, drug treatment and health- related quality of life in patients with inflammatory bowel disease five years after initial diagnosis. Eur J Gastroenterol Hepatol 2005; 17: 1037-45.
129. Feagan BG, Rainisch W, Rutgeerts P et al. The effects of infliximab therapy on health- related quality of life in ulcerative colitis patients. Am J Gastroenterol 2007; 102: 794-802.
130. Rutgeerts P, Schreiber S, Feagan B et al. Certolizumab pegol, a monthly subcutaneously administered Fc-free anti-TNF a, improves health-related quality of life in patients with moderate to severe Crohn’s disease. Int J Colorectal Dis 2008; 23: 289-96.
131. Colombel JF, Loftus EV, Feagan BG et al. Impact of adalimumab (Humira®) on patient- reported outcomes among patients with fistulizing Crohn’s disease in the Charm trial. Gut 2007; 56 (Suppl III): A149.
132. Bernklev T, Jahnsen J, Henriksen M et al. Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis 2006; 12: 412-12.
133. Feagan BG, Bala M, Yan S et al. Unemployment and disability in patients with moderately to severely active Crohn’s disease. J Clin Gastroenterol 2005; 39: 390-5.
134. Lichtenstein GR, Yan S, Bala M et al. Remission in patients with Crohn’s disease is associated with improvement in employment and quality of life and a decrease in hospitalizations and surgeries. Am J Gastroenterol 2003; 1: 91-6.
135. Reinisch W, Sandborn WJ, Bala M et al. Response and remission are associated with improved quality of life, employment and disability status, hours worked, and productive of patients with ulcerative colitis. Inflamm Bowel Dis 2007; 13; 1135-1140.
136. Bernklev T, Jahnssen J, Lygren I. Health-related quality of life in inflammatory bowel disease patients measured with the short-form 36: psychometric assessments and comparison with general population norms. Inflamm Bowel Dis 2005; 11: 908-11.
THE IMPACT OF INFLAMMATORY BOWEL DISEASE IN CANADA 93
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96